Support the construction of high standard industrial park to provide production area for API development

[market analysis of chinapharma.com] APIs or active pharmaceutical ingredients (APIs) are pharmaceutical substances that provide formula drugs China is a big producer of APIs, with more than 2000 related enterprises, with an annual output of more than 1 million tons, accounting for 16% of the total revenue of the pharmaceutical industry However, in recent years, due to the impact of environmental protection shutdown and other factors, the prices of some products have risen and the supply of APIs is tight With the intensification of environmental protection pressure in 2018, more API prices may rise, which will become a hidden danger affecting the development of health industry Facing the strengthening of green development trend, how to transform and upgrade API to achieve better development? It has become one of the focuses of the pharmaceutical industry in China "Suggestions on further improving centralized drug procurement in public hospitals" points out that environmental protection supervision can force API enterprises to transform and upgrade, and eliminate backward enterprises, but the implementation process should remember "one size fits all", at the same time, it should also support the construction of high-standard API parks to provide production areas for API development At present, the API industry is still in a "scattered, disordered and small" pattern Some small-scale API manufacturers maliciously reduce the price of API, resulting in low-cost vicious competition The production equipment of small manufacturers is backward, the production input is low, the quality of APIs produced is uneven, and even the substandard ones are circulated to the market I have learned that with the increasingly strict enforcement of environmental protection law, many pharmaceutical enterprises have "stumbled" due to poor environmental protection In recent years, with the introduction of relevant environmental protection standards and policies, the living space of API industry has been "suppressed" For example, in July 2010, the Ministry of environmental protection issued and fully enforced the discharge standard of water pollutants in pharmaceutical industry; in 2013, the Ministry of environmental protection made comprehensive investigation and remediation of environmental pollution in pharmaceutical industry as the third major task of special environmental protection action; in 2014, the illegal environment in pharmaceutical manufacturing was still the target of key remediation by relevant ministries and commissions, and the red line of pharmaceutical environmental protection was "tight"; in April 2015 In 2016, the environmental protection tax law was issued to change the environmental protection fee into environmental protection tax, and the high pollution industries such as API will be subject to heavy tax However, in the 13th five year plan for ecological environment protection issued in December 2016, API manufacturing industry is required to promote the transformation of the industry's up to standard emissions Facing the increasingly tightening of green environmental protection policies, backward, low-level and repeated construction, and excessive pollution enterprises at the expense of the environment will be difficult to survive The ability and cost of pollution control will become the core competitive factors of pharmaceutical enterprises in the future In this process, some pharmaceutical enterprises are still transforming to downstream preparations In addition, the development of API by pharmaceutical enterprises has become one of the important aspects of enterprise transformation The construction of API base will help enterprises to survive It is understood that the global clinical API production is mainly concentrated in North America, the European Union and India, and the commercial API production is mainly concentrated in North America, the European Union, Puerto Rico and Singapore According to the industry, while ensuring the stable growth of bulk APIs, China should optimize the product structure, realize industrial upgrading and develop towards APIs and preparations In order to promote the development of API, China should vigorously support the construction of high standard API park to provide the origin for API development In 2018, the pressure on environmental protection will be more and more intense For example, at the beginning of the new year, the regulations for the implementation of the environmental protection tax law of the people's Republic of China will be officially implemented, and high pollution industries such as APIs will face heavy tax test In order to promote the transformation of API, some enterprises also began to increase the progress It is understood that kailihe pharmaceutical, which is committed to building the Western API base, will have an annual output value of 380 million yuan and an annual profit and tax of 60 million yuan after the project is put into full production The refinement, serialization and development of bulk API will become the mainstream trend of API in the future China will encourage enterprises to reduce energy and resource consumption through technological innovation, promote the development of API, improve product technology content and added value, and promote the better development of API